Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

NCT00191789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: gemcitabine
DRUG: doxorubicin
DRUG: cisplatin
PROCEDURE: surgery

Sponsor

Eli Lilly and Company